Apex Biotechnology Corp.

TWSE:1733 Voorraadrapport

Marktkapitalisatie: NT$2.9b

Apex Biotechnology Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Thomas Y. Shen

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEO10.4%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuur6.8yrs

Recente managementupdates

Recent updates

Apex Biotechnology (TWSE:1733) Will Be Hoping To Turn Its Returns On Capital Around

Aug 06
Apex Biotechnology (TWSE:1733) Will Be Hoping To Turn Its Returns On Capital Around

Apex Biotechnology's (TWSE:1733) Conservative Accounting Might Explain Soft Earnings

Mar 21
Apex Biotechnology's (TWSE:1733) Conservative Accounting Might Explain Soft Earnings

Apex Biotechnology's (TPE:1733) Returns On Capital Not Reflecting Well On The Business

Apr 17
Apex Biotechnology's (TPE:1733) Returns On Capital Not Reflecting Well On The Business

Is Apex Biotechnology (TPE:1733) Using Too Much Debt?

Mar 30
Is Apex Biotechnology (TPE:1733) Using Too Much Debt?

Is Apex Biotechnology Corp. (TPE:1733) A Good Fit For Your Dividend Portfolio?

Mar 10
Is Apex Biotechnology Corp. (TPE:1733) A Good Fit For Your Dividend Portfolio?

Is Apex Biotechnology Corp.'s (TPE:1733) Stock On A Downtrend As A Result Of Its Poor Financials?

Feb 17
Is Apex Biotechnology Corp.'s (TPE:1733) Stock On A Downtrend As A Result Of Its Poor Financials?

A Look At Apex Biotechnology's (TPE:1733) Share Price Returns

Jan 27
A Look At Apex Biotechnology's (TPE:1733) Share Price Returns

Returns On Capital At Apex Biotechnology (TPE:1733) Paint An Interesting Picture

Jan 06
Returns On Capital At Apex Biotechnology (TPE:1733) Paint An Interesting Picture

These 4 Measures Indicate That Apex Biotechnology (TPE:1733) Is Using Debt Safely

Dec 16
These 4 Measures Indicate That Apex Biotechnology (TPE:1733) Is Using Debt Safely

Is Apex Biotechnology Corp.'s (TPE:1733) 4.5% Dividend Worth Your Time?

Nov 22
Is Apex Biotechnology Corp.'s (TPE:1733) 4.5% Dividend Worth Your Time?

CEO

Thomas Y. Shen

no data

Tenure

Dr. Thomas Y. S. Shen, Ph D serves as Chairman, Chief Executive Officer and General Manager of Apex Biotechnology Corp. Dr. Shen served as Supervisor/Corporate Representative at Sheng Da Venture Capital. D...

Bestuursleden

NaamPositieTenureCompensatieEigendom
Thomas Y. Shen
Chairmanno datageen gegevens10.38%
NT$ 302.4m
Meng Yang
Vice GMno datageen gegevens0.28%
NT$ 8.2m
Yung-Luh Tsaih
Independent Director3.3yrsgeen gegevensgeen gegevens
I-Tan Chih
Independent Directorno datageen gegevensgeen gegevens
Pai Ming
Independent Director6.8yrsgeen gegevensgeen gegevens
Jin-Chang Bou
Independent Director6.8yrsgeen gegevensgeen gegevens

6.8yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van 1733 wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.8 jaar).